BLOG

Does NK Cell Activity Decline? What It Means for Therapy

8 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

If you or a family member is living with cancer, you may have read that natural killer (NK) cell activity can change over time. It is a reasonable question to ask: do age, stress, and the illness itself affect these immune cells, and what does that mean for NK cell therapy? This article explains the basic idea in plain language and lists questions worth bringing to a doctor. It is general information, not medical advice, and it cannot tell you whether any treatment is right for you.

What NK cells do in the body

NK cells are a type of lymphocyte, a white blood cell that circulates in the blood. They belong to the innate immune system, which means they can recognize and attack abnormal cells, such as cancer cells and virus-infected cells, without waiting for instructions from other immune cells. This is where the name “natural killer” comes from.

Researchers often describe this role as immune surveillance. Even in healthy people, abnormal cells that could develop into cancer are thought to arise from time to time, and immune cells including NK cells help find and remove them. When this surveillance weakens, abnormal cells may be more likely to escape notice. This is a simplified model, and cancer development involves many factors beyond NK cells.

Why NK cell activity may decline

According to the information provided by Grand Green Osaka Umekita Clinic, NK cell activity is known to decline with age, with stress, and with the effects of cancer itself. Published research on NK cells points in a similar direction, although results differ between studies, between cancer types, and between individuals. A single blood test value does not tell the whole story, and a lower or higher result should always be interpreted by a physician who knows your history.

It is also important not to overstate this point. Changes in NK cell activity do not by themselves determine whether a person will develop or overcome cancer. They are one part of a much larger picture that includes the type and stage of the disease, overall health, and the standard treatment being received.

How NK cell therapy relates to this idea

NK cell therapy is an immune cell therapy that uses your own cells. In the approach described by the clinic, NK cells are collected from a standard blood draw, activated and expanded at a specialized cell processing facility, and then returned to the body by intravenous infusion. The aim is to return a larger number of more active NK cells to help support immune function that may have weakened.

Because the cells come from your own body, they are called autologous cells. The clinic notes that the risk of rejection is considered low and that serious side effects have rarely been reported, but temporary fever or fatigue may occur. No treatment is free of risk, and individual responses vary. The treatment does not involve hospitalization, so many people continue their daily routines, but the practical details should be confirmed at a consultation.

It is equally important to understand the limits. NK cell therapy is not a guaranteed way to restore immune function, and it should not be understood as a replacement for surgery, chemotherapy, radiation therapy, or other standard cancer treatment. Where it is considered, it is usually discussed alongside standard care, and the clinic says it can coordinate with the medical institution that provides your standard treatment.

Questions to ask a doctor before deciding

Because the science on immune cells is complex, the most useful step is a structured conversation with a doctor. The following questions can help you prepare for a consultation:

  • What is known, and not yet known, about the evidence for NK cell therapy for my type and stage of cancer?
  • Is measuring NK cell activity part of the assessment, and how would the result change the discussion?
  • How would this therapy fit with my current or planned standard treatment, and who will coordinate with my oncologist?
  • What side effects and risks should I expect, and what happens if I develop a fever or fatigue after an infusion?
  • What are the total costs, how many sessions are usually planned, and what is the expected schedule?
  • Who may not be suitable for this therapy, and what would a doctor need to check first?

Please bring your recent test results, imaging reports, and a list of current medicines. If you are being treated elsewhere, ask your current doctor whether the timing of any new treatment matters.

Cost, legal framework, and what to confirm

NK cell therapy is provided as a self-pay (non-insured) treatment in Japan, which means it is not covered by public health insurance. In Japan, cell therapies of this kind are provided under the Act on the Safety of Regenerative Medicine, which requires a treatment plan to be reviewed by a certified committee and submitted to the Ministry of Health, Labour and Welfare. This is a framework for safety management, and it does not by itself guarantee that a treatment will work for any individual.

Fees, the number of sessions, risks, side effects, and whether you are a suitable candidate can only be confirmed through a medical consultation. Be cautious of any provider who promises a specific result or who discourages you from continuing standard treatment. A good consultation should clearly describe both the possible benefits and the uncertainties.

Consulting in Osaka as an international patient

Grand Green Osaka Umekita Clinic is located in the Umeda area of Osaka, a city with convenient rail and airport connections. The clinic provides information pages in several languages, including a page for international patients, so that you can review the treatment overview, flow, fees, and frequently asked questions before you make contact. You can reach the clinic through its website or messaging channels to ask about a consultation.

If you are traveling from overseas, it can help to prepare a short summary of your diagnosis and treatment history, translated if possible, and to ask in advance how language support will work during your visit. Reading the multilingual pages first can make the first conversation more efficient.

Key points to remember

NK cells are part of the innate immune system and are involved in immune surveillance. Their activity is known to decline with age, stress, and the effects of cancer, but the meaning of this for any single person is not simple. NK cell therapy aims to return activated and expanded NK cells to the body, and it is discussed as an option that may be used alongside standard cancer treatment rather than instead of it. A doctor’s consultation is the right place to talk about evidence, risks, costs, and whether this therapy fits your situation.

References

Supervising Physician

Hidenori Shimada

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Grand Green Osaka South Building, Gate Tower 5F 5-54 Ofuka-cho, Kita-ku, Osaka 530-0011, Japan

TEL: 06-7653-8493 FAX: 06-7635-8052

Contact